Next Article in Journal / Special Issue
Clinicopathological Phenotype and Genetics of X-Linked Dystonia–Parkinsonism (XDP; DYT3; Lubag)
Previous Article in Journal
The Role of Peripheral CNS‐Directed Antibodies in Promoting Inflammatory CNS Demyelination
Previous Article in Special Issue
Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)
Article Menu

Export Article

Open AccessCase Report
Brain Sci. 2017, 7(7), 71;

Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations

Department of Neurology, Vanderbilt University Medical Center, 1301 Medical Center Dr. Suite 3930, Nashville, TN 37232-5400, USA
Department of Pediatrics, Pediatric Neurology, Vanderbilt University Medical Center, Nashville, TN 37232-2594, USA
Author to whom correspondence should be addressed.
Academic Editors: Steven Frucht and Pichet Termsarasab
Received: 31 May 2017 / Revised: 18 June 2017 / Accepted: 21 June 2017 / Published: 24 June 2017
(This article belongs to the Special Issue Pathophysiology and Genetics of Movement Disorders)
Full-Text   |   PDF [2810 KB, uploaded 24 June 2017]   |  
  |   Review Reports


PARK2 mutations are the most common cause of early-onset Parkinson’s disease. No genotype-phenotype correlation exists, and phenotypic variability is quite common. We report two siblings with confirmed identical compound heterozygous mutations in the PARK2 gene manifesting strikingly different phenotypes. The older brother demonstrated marked parkinsonism by his mid-20’s, whereas the younger brother developed exercise-induced dystonia in his mid-30’s with no subsequent clinical progression, highlighting the clinical heterogeneity of the disease and implying the role of other genetic and/or environmental factors in disease progression. The younger sibling, despite his mild symptoms, had a clearly abnormal dopamine transporter (DaT)-SPECT scan. To our knowledge, this is the first such reported case of an abnormal DaT-SPECT scan in a patient with biallelic PARK2 mutations who does not meet the clinical criteria for Parkinson’s disease. View Full-Text
Keywords: PARK2; parkin; Parkinson’s disease; DAT-SPECT PARK2; parkin; Parkinson’s disease; DAT-SPECT

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Isaacs, D.; Claassen, D.; Bowman, A.B.; Hedera, P. Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations. Brain Sci. 2017, 7, 71.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top